Streetbeat News

Regulatory

EFTRW

Trading for EFTRW has been halted at 7:50:00 p.m. ET due to pending news. The halt is in place to manage market orderliness and ensure fair information dissemination pending the release of significant news.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 12:50 am

SVFD

Save Foods, Inc. has filed a prospectus related to the potential resale of up to 6.7 million shares of its common stock from time to time. The filing was made through an S-1 form with the relevant regulatory authorities.

Portfolio Pulse from Charles Gross

January 11, 2024 | 10:31 pm

CHH

WH

Wyndham has received a Second Request from the FTC under the HSR Act regarding Choice's unsolicited hostile offer. Wyndham's Chairman, Stephen P. Holmes, stated that the FTC's decision was expected and reiterated that the offer undervalues Wyndham and poses significant risk to its shareholders.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 10:11 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is halting most production at its Giga Berlin factory for two weeks due to disruptions in the Red Sea affecting shipping routes. The conflict in the Red Sea, which accounts for 12% of global maritime traffic, has led to attacks on shipping vessels, causing companies like Tesla to experience longer transportation times and supply chain issues. Major shipping companies are altering their routes to avoid the region, leading to increased costs and delays.

Portfolio Pulse from Chris Katje

January 11, 2024 | 9:57 pm

LLY

NVO

The FDA's preliminary review found no evidence that weight-loss drugs, specifically GLP-1 RAs, cause suicidal thoughts. This class includes Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound. The FDA cannot definitively rule out a small risk and will continue its investigation. The European Medicines Agency is also reviewing semaglutide, the active ingredient in Wegovy and Ozempic, after reports of suicidal thoughts.

Portfolio Pulse from Erica Kollmann

January 11, 2024 | 9:55 pm

TUP

Tupperware Brands has been notified by the NYSE of non-compliance due to not holding its Fiscal Year 2022 Annual Meeting. The company is taking steps to regain compliance with NYSE regulations.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 9:36 pm

EOG

EOG Resources Inc reported in an SEC filing that it expects a net gain of $298 million from mark-to-market of its financial commodity derivative contracts for Q4 2023. Additionally, the company received $18 million in net cash from settlements of these contracts during the same quarter.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 9:31 pm

BLK

BTCUSD

ETHUSD

Industry experts predict the approval of Ethereum (ETH) ETFs following the U.S. regulators' approval of Bitcoin (BTC) ETFs. They anticipate significant market interest and a shift in investment focus from Bitcoin to Ethereum, highlighting the potential for staking yields and broader investment opportunities with Ethereum. BlackRock Inc. (NYSE:BLK) is mentioned as having ETF applications, indicating institutional interest in Ethereum.

Portfolio Pulse from Murtuza Merchant

January 11, 2024 | 9:29 pm

FTFT

The SEC has charged the CEO of Future FinTech (FTFT) with fraud and disclosure failures, according to a Reuters report. The nature of the fraud and specific disclosure issues were not detailed in the summary provided.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 9:28 pm

VBIV

VBI Vaccines Inc. and its subsidiary VBI Cda, collectively known as the Borrowers, have extended their forbearance agreement with K2 HealthVentures LLC and other lenders until January 23, 2024. This agreement pertains to a covenant breach regarding minimum Net Revenue for the period ended September 30, 2023. The forbearance period has been extended multiple times, with the latest extension effective January 9, 2024. There is no guarantee that VBI Vaccines will meet the Forbearance Agreement conditions, which could lead to K2HV declaring an Event of Default. This would allow K2HV to demand immediate payment of all obligations and cease any further credit advances, with an additional interest penalty of 5.00% per annum.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 9:25 pm